Captrust Financial Advisors Gritstone Bio, Inc. Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 36,600 shares of GRTS stock, worth $1,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,600

Previous 38,659 5.33%

Holding current value

$1,098

Previous $23,000 8.7%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.45 - $0.71 $926 - $1,461	-2,059 Reduced 5.33%	36,600 $21,000
Q2 2024 Aug 14, 2024	BUY	$0.62 - $2.35 $32 - $124	53 Added 0.14%	38,659 $23,000
Q1 2024 May 15, 2024	BUY	$1.96 - $2.9 $19,453 - $28,782	9,925 Added 34.6%	38,606 $99,000
Q4 2023 Feb 14, 2024	SELL	$1.28 - $2.85 $140,721 - $313,326	-109,939 Reduced 79.31%	28,681 $58,000
Q3 2023 Nov 14, 2023	SELL	$1.19 - $2.26 $51,543 - $97,889	-43,314 Reduced 23.81%	138,620 $238,000
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.03 $8,300 - $15,149	-5,000 Reduced 2.67%	181,934 $354,000
Q3 2022 Nov 16, 2022	BUY	$2.46 - $4.75 $118,048 - $227,938	47,987 Added 34.54%	186,934 $480,000
Q2 2022 Aug 16, 2022	BUY	$1.77 - $4.34 $51,590 - $126,497	29,147 Added 26.55%	138,947 $336,000
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $118,079 - $357,167	29,300 Added 36.4%	109,800 $452,000
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $222,504 - $348,234	25,400 Added 46.1%	80,500 $1.04 Million
Q3 2021 Nov 16, 2021	BUY	$6.41 - $13.54 $214,735 - $453,590	33,500 Added 155.09%	55,100 $595,000
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $90,243 - $113,219	11,100 Added 105.71%	21,600 $197,000
Q1 2021 May 17, 2021	SELL	$4.07 - $27.11 $266,112 - $1.77 Million	-65,384 Reduced 86.16%	10,500 $99,000
Q4 2020 Feb 16, 2021	SELL	$2.57 - $4.22 $100,230 - $164,580	-39,000 Reduced 33.95%	75,884 $299,000
Q3 2020 Nov 17, 2020	SELL	$2.63 - $8.09 $3,603 - $11,083	-1,370 Reduced 1.18%	114,884 $309,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $70,556 - $101,308	12,400 Added 11.94%	116,254 $761,000
Q1 2020 May 15, 2020	BUY	$5.47 - $11.3 $346,798 - $716,420	63,400 Added 156.72%	103,854 $591,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $11.61 $286,009 - $469,670	40,454 New	40,454 $329,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Gritstone Bio, Inc. Transaction History